Invivyd authors evaluated early side effects of prior low-dose investigational monoclonal antibody adintrevimab from the EVADE study, demonstrating minimal tolerability issues Results allow for ...
By Mariam Sunny and Jennifer Rigby May 29 (Reuters) - Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic Republic of Congo, linked ...
Unlike the more common Zaire strain, for which approved vaccines and treatments exist, there are currently no specific ...
Plus, when it will actually be available in the U.S.
The fast-growing Ebola outbreak in the Democratic Republic of Congo came to the world’s attention only a little more than a ...
The next pandemic may arrive in the United States via cruise ship or commercial flight originating halfway around the world.
Drugs in development to treat and prevent infections caused by the Ebola virus that’s circulating in the Democratic Republic of Congo and Uganda should be given only as part of clinical trials, ...
Achieved Q1 2026 PEMGARDA® (pemivibart) net product revenue of $13.7 million, representing 22% growth versus Q1 2025 net product revenue of $11.3 ...
Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results